Page last updated: 2024-09-04

methyl 5-aminolevulinate and Disease Exacerbation

methyl 5-aminolevulinate has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV	1
Kloser, A; Lee, PK	1
Liang, WM; Lim, KS; Tan, WP; Theng, TS	1
Choi, JW; Huh, CH; Jung, JY; Kim, BJ; Lee, JH; Park, KC; Yeon, JH; Youn, SW	1

Reviews

1 review(s) available for methyl 5-aminolevulinate and Disease Exacerbation

Article	Year
Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT. Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:8 Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Disease Progression; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; United States	2013

Trials

1 trial(s) available for methyl 5-aminolevulinate and Disease Exacerbation

Article	Year
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. The British journal of dermatology, 2018, Volume: 179, Issue:5 Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2018

Article

Year

Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.

The British journal of dermatology, 2018, Volume: 179, Issue:5

Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

2018

Other Studies

2 other study(ies) available for methyl 5-aminolevulinate and Disease Exacerbation

Article	Year
Rapid development of squamous cell carcinoma after photodynamic therapy. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:5 Topics: Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Squamous Cell; Disease Progression; Facial Neoplasms; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2014
Keratoacanthoma aggravated after photodynamic therapy. The Journal of dermatology, 2010, Volume: 37, Issue:8 Topics: Aminolevulinic Acid; Disease Progression; Humans; Keratoacanthoma; Male; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2010

Article

Year

Rapid development of squamous cell carcinoma after photodynamic therapy.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:5

Topics: Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Squamous Cell; Disease Progression; Facial Neoplasms; Female; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2014

Keratoacanthoma aggravated after photodynamic therapy.

The Journal of dermatology, 2010, Volume: 37, Issue:8

Topics: Aminolevulinic Acid; Disease Progression; Humans; Keratoacanthoma; Male; Middle Aged; Nose Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2010